Table 4 Drug treatment of seizures and mental disorders in the 12Â months prior to first documentation
Comorbidity category (n of afflicted patients) | Substance | Patient number | ≤13 years (n = 40) | 14-17 years (n = 11) | 18+ years (n = 24) | Total (all patients, n = 75) |
|---|---|---|---|---|---|---|
n (%) | n (%) | n (%) | n (%) | |||
ADH (36) | Amphetamine | 9 (37.5) | 4 (57.1) | 1 (20.0) | 13 (17.1) | |
Atomoxetine, Desipramine, etc. | 0 | 1 (14.3) | 0 | 2 (2.6) | ||
Methylphenidate | 9 (37.5) | 3 (42.9) | 1 (20.0) | 14 (18.4) | ||
Risperidone, Quetiapine, etc. | 3 (12.5) | 1 (14.3) | 0 | 6 (7.9) | ||
Other | 11 (45.8) | 2 (28.6) | 1 (20.0) | 14 (18.4) | ||
Anxiety (22) | Fluoxetine, Fluvoxamine, etc. | 5 (41.7) | 2 (66.7) | 2 (28.6) | 9 (11.8) | |
Amitriptyline, Imipramine, etc. | 0 | 0 | 0 | Â | ||
Diazepam, Lorazepam, etc. | 0 | 0 | 0 | Â | ||
Risperidone, Clozapine, etc. | 0 | 0 | 2 (28.6) | 2 (2.6) | ||
Other | 6 (50.0) | 2 (66.7) | 1 (14.3) | 9 (11.8) | ||
Conduct disorders (39) | Methylphenidate, Amphetamine, etc. | 8 (36.4) | 2 (33.3) | 2 (18.2) | 12 (15.8) | |
Pipamperone, Melperone, etc. | 0 | 0 | 0 | 1 (1.3) | ||
Risperidone, Clozapine, etc. | 5 (22.7) | 0 | 2 (18.2) | 10 (13.2) | ||
Other | 14 (63.6) | 4 (66.7) | 4 (36.4) | 23 (30.3) | ||
Depression (7) | Fluvoxamine, Citalopram, etc. | 2 (66.7) | 1 (100.0) | 1 (33.3) | 4 (5.3) | |
Venlafaxine, Bupropion, etc. | 0 | 1 (100.0) | 0 | Â | ||
Lithium | Â | 1 (100.0) | Â | Â | ||
Other | 1 (33.3) | 0 | 0 | 1 (1.3) | ||
Seizures (6) | Valproate | 1 (20.0) | 0 | 1 (100.0) | 2 (2.6) | |
Other | 3 (60.0) | 0 | 1 (100.0) | 6 (7.9) | ||